Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?

导出 LinkOut

翻译打印收藏纠错

第一作者： Davide,Seripa

第一单位： a Complex Structure of Geriatrics, Department of Medical Sciences , IRCCS "Casa Sollievo della Sofferenza" , San Giovanni Rotondo , Foggia , Italy.

作者： Davide,Seripa ^[1] ; Madia,Lozupone ^[2] ; Eleonora,Stella ^[3] ; Giulia,Paroni ^[1] ; Paola,Bisceglia ^[1] ; Maddalena,La Montagna ^[3] ; Grazia,D'onofrio ^[1] ; Carolina,Gravina ^[1] ; Maria,Urbano ^[1] ; Maria Giovanna,Priore ^[2] ; Angela,Lamanna ^[2] ; Antonio,Daniele ^[4] ; Antonello,Bellomo ^[3] ; Giancarlo,Logroscino ^[2] ; Antonio,Greco ^[5] ; Francesco,Panza ^[1]

作者单位： a Complex Structure of Geriatrics, Department of Medical Sciences , IRCCS "Casa Sollievo della Sofferenza" , San Giovanni Rotondo , Foggia , Italy. ^[1] b Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs , University of Bari Aldo Moro , Bari , Italy. ^[2] c Psychiatric Unit, Department of Clinical and Experimental Medicine , University of Foggia , Foggia , Italy. ^[3] d Institute of Neurology , Catholic University of Sacred Heart , Rome , Italy. ^[4] e Department of Clinical Research in Neurology , University of Bari Aldo Moro, "Pia Fondazione Cardinale G. Panico" , Tricase , Lecce , Italy. ^[5]

关键词 Adverse drug reaction cytochrome P450 late-life neurological disorders late-life psychiatric disorders therapeutic failure